Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01475149 · ClinicalTrials.gov registry record
Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)
A clinical trial, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- 33
- Enrollment target
NCT01475149: Completed study, sponsored by Hospital for Special Surgery, New York.
NCT01475149 is a clinical trial that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01475149 has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
This 12 week study will observe patients with and without systemic lupus erythematosus who have persistent antiphospholipid antibodies in the blood who are starting a medicine called hydroxychloroquine. It will measure if these patients have a change in a blood test called the annexin A5 resistance assay over that 12 week period.
Primary Outcome
The primary goal of the study is to compare results of the AnxA5 resistance assay from patients before they start taking HCQ and after they have taken it for 12 weeks to see if the results of the blood test change.
Interventions
- OTHER Phlebotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2010-09 |
| Est. Completion | 2016-08 |
What the finished NCT01475149 record still lists
NCT01475149 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Phlebotomy is the first listed.
NCT01475149 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01475149 about?
NCT01475149 is a clinical study titled "Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)". This 12 week study will observe patients with and without systemic lupus erythematosus who have persistent antiphospholipid antibodies in the blood who are starting a medicine called hydroxychloroquine. It will measure if these patients have a change in a blood test called the annexin A5 resistance ...
What is the current status of trial NCT01475149?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2010-09. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01475149?
The interventions under investigation include: Phlebotomy (OTHER).
Who is sponsoring clinical trial NCT01475149?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia